LPL Financial’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History

LPL Financial’s Portfolio PVCT Stock Details PVCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-59,200	Closed	-$5K	–	2858
2016 Q3	$5K	Hold	59,200	–	–	﹤0.01%	2627
2016 Q2	$21K	Sell	59,200 -59,200	-50%	-$22.5K	﹤0.01%	2590
2016 Q1	$43K	Hold	118,400	–	–	﹤0.01%	3016
2015 Q4	$47K	Buy	118,400 +59,200	+100%	+$28.1K	﹤0.01%	3048
2015 Q3	$33K	Sell	59,200 -2,000	-3%	-$1.02K	﹤0.01%	2736
2015 Q2	$32K	Hold	61,200	–	–	﹤0.01%	2826
2015 Q1	$49K	Sell	61,200 -2,000	-3%	-$1.65K	﹤0.01%	2725
2014 Q4	$51K	Buy	63,200 +16,000	+34%	+$14.6K	﹤0.01%	2665
2014 Q3	$47K	Buy	47,200 +2,000	+4%	+$1.94K	﹤0.01%	2649
2014 Q2	$39K	Buy	+45,200	New	+$54.2K	﹤0.01%	2635

Other funds holding PVCT

CCB

Cutter & Co Brokerage Ballwin, Missouri $423M AUM 15.02% 1-Year Est. Return

HFBOT

Home Federal Bank of Tennessee Knoxville, Tennessee $463M AUM 24.62% 1-Year Est. Return

LPL Financial's PVCT Position: Q4 2016 in Review

LPL Financial sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q4 2016, closing a stake of 59,200 shares — an estimated $5K sold.

LPL Financial first reported a position in PVCT in Q2 2014 and held it in 10 quarters. The position peaked at $51K in Q4 2014. 8 funds tracked by Wall St. Rank hold PVCT as of Q4 2016.

LPL Financial reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q4 2016 after selling out during the quarter.
LPL Financial sold 59,200 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q4 2016, an estimated $5K.
LPL Financial first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 10 quarters.
LPL Financial's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $51K in Q4 2014.
8 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q4 2016.

Based on LPL Financial's 13F filing for Q4 2016, filed 13 Feb 2017.